NCT00006182View on ClinicalTrials.gov

Stroke Prevention in Sickle Cell Anemia (STOP 2)

PHASE3CompletedINTERVENTIONAL

Timeline

Start Date

July 31, 2000

Study Completion Date

February 28, 2006

Conditions

Blood DiseaseCerebrovascular AccidentAnemia, Sickle Cell

Interventions

PROCEDURE

Blood Transfusion

All Listed Sponsors

lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT00006182 - Stroke Prevention in Sickle Cell Anemia (STOP 2) | Biotech Hunter | Biotech Hunter